Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Shares Issued (2019 - 2025)

Outset Medical (OM) has disclosed Shares Issued for 7 consecutive years, with $231000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued rose 90.91% to $231000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $639000.0, a 72.02% decrease, with the full-year FY2025 number at $639000.0, down 72.02% from a year prior.
  • Shares Issued was $231000.0 for Q3 2025 at Outset Medical, down from $408000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $6.2 million in Q3 2021 to a low of $4000.0 in Q4 2023.
  • A 5-year average of $1.9 million and a median of $1.0 million in 2023 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: soared 14686.67% in 2021, then crashed 99.34% in 2023.
  • Outset Medical's Shares Issued stood at $934000.0 in 2021, then plummeted by 34.8% to $609000.0 in 2022, then plummeted by 99.34% to $4000.0 in 2023, then soared by 2925.0% to $121000.0 in 2024, then skyrocketed by 90.91% to $231000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Shares Issued are $231000.0 (Q3 2025), $408000.0 (Q1 2025), and $121000.0 (Q3 2024).